Institutional investors hold a majority ownership of MRK through the 75.88% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended March 2017, these large investors purchased a net $7.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 13.6 Million shares of Merck
RENAISSANCE TECHNOLOGIES LLC Bought 7.4 Million shares of Merck
THE VANGUARD GROUP, INC. Bought 6.1 Million shares of Merck